Sign In
Buy EVGN
$0.599
+0.0089 (+1.51%)
At Close: Jun 03, 2026
ARKG: Potential Disruption For Healthcare And Pharma Industries
01:56pm, Tuesday, 19'th Jan 2021
ARKG: Potential Disruption For Healthcare And Pharma Industries
Canonic Announces Signing of First Cultivation Agreement for its Medical Cannabis Varieties
07:00am, Wednesday, 23'rd Dec 2020
REHOVOT, Israel, Dec. 23, 2020 /PRNewswire/ -- Canonic Ltd, a company focused on the development of medical cannabis products and a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN)
5 Sizzling Stocks to Buy Trading Under $10 With Massive Upside Potential
06:25am, Saturday, 12'th Dec 2020
While most of Wall Street focuses on large and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
Evogene Ltd. (EVGN) CEO Ofer Haviv on Q3 2020 Results - Earnings Call Transcript
03:20pm, Wednesday, 18'th Nov 2020
Evogene Ltd. (EVGN) CEO Ofer Haviv on Q3 2020 Results - Earnings Call Transcript
Evogene Financial Results and Earnings Announcement Schedule for the Third Quarter of 2020
07:00am, Monday, 02'nd Nov 2020
REHOVOT, Israel, Nov. 2, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several
Evogene Prices $12 Million Registered Direct Offering
09:11am, Friday, 30'th Oct 2020
REHOVOT, Israel, Oct. 30, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN), a leading computational biology company focused on revolutionizing product discovery and development in multip
Evogene: Hidden Gems Of Computational Predictive Biology (Part 3 Of 4) - Ag Plenus (Novel Herbicides And Pesticides)
10:48am, Wednesday, 02'nd Sep 2020
Evogene's 100% owned subsidiary AgPlenus utilizes Evogene's computational predictive biology platform to develop Ag-Chemicals (novel herbicides, insecticides and other crop control products).
Evogene: Hidden Gems Of Computational Predictive Biology, Part 2 Of 4 - Lavie Bio
10:08am, Monday, 24'th Aug 2020
Evogene's 72% owned subsidiary Lavie Bio Ltd. focuses on Microbiome based Ag-biologicals: microbial and naturally derived biostimulants and biopesticides.
Evogene to Present at LD 500 Virtual Conference
11:00am, Wednesday, 19'th Aug 2020
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development across several market segments including ag-biologicals
Evogene: Hidden Gems Of Computational Predictive Biology, Part 1 Of 4 (Biomica, Microbiome Therapeutics)
08:55pm, Thursday, 13'th Aug 2020
Evogene Ltd. has developed a unique Computational Predictive Biology platform, leveraging big data and artificial intelligence to life-science products such as microbes, small molecules and genes.
LD Micro Announces Preliminary List of Presenters for the LD 500.
03:37pm, Wednesday, 05'th Aug 2020
LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively onlin
Evogene Reports Second Quarter 2020 Financial Results
11:00am, Wednesday, 05'th Aug 2020
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development across several market segments, announced today its fin
Evogene to Present at Jefferies Virtual 2020 Industrials Conference
11:00am, Wednesday, 29'th Jul 2020
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading artificial intelligence company targeting to revolutionize life-science product development across several market segments utilizing computationa
Evogene Financial Results and Earnings Announcement Schedule for the Second Quarter of 2020
11:00am, Wednesday, 15'th Jul 2020
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development across several market segments, announces today that it
